Lactoferrin potently inhibits osteoblast apoptosis, via an LRP1-independent pathway

Molecular and Cellular Endocrinology

Volumn 251, Issue 1-2, 2006, Pages 96-102

  Grey, Andrew ^a   Zhu, Qing ^a   Watson, Maureen ^a   Callon, Karen ^a   Cornish, Jill ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Apoptosis; Lactoferrin; LRP1; Osteoblast

Indexed keywords

LACTOFERRICIN; LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FIBROBLAST; IN VIVO STUDY; MOLECULAR MECHANICS; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FIBROBLASTS; HUMANS; LACTOFERRIN; LDL-RECEPTOR RELATED PROTEIN 1; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION;

EID: 33646550545     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2006.03.002     Document Type: Article

References (36)

1. Ajello M., Greco R., Giansanti F., Massucci M.T., Antonini G., and Valenti P. Anti-invasive activity of bovine lactoferrin towards group A streptococci. Biochem. Cell Biol. 80 (2002) 119-124
2. Baveye S., Elass E., Mazurier J., Spik G., and Legrand D. Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin. Chem. Lab. Med. 37 (1999) 281-286
3. Boucher P., Liu P., Gotthardt M., Hiesberger T., Anderson R.G., and Herz J. Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J. Biol. Chem. 277 (2002) 15507-15513
4. Bu G.J. Receptor-associated protein: a specialized chaperone and antagonist for members of the LDL receptor gene family. Curr. Opin. Lipidol. 9 (1998) 149-155
5. Cornish J., Callon K.E., Naot D., Palmano K.P., Banovic T., Bava U., Watson M., Lin J.M., Tong P.C., Chen Q., Chan V.A., Reid H.E., Fazzalari N., Baker H.M., Baker E.N., Haggarty N.W., Grey A.B., and Reid I.R. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145 (2004) 4366-4374
6. Datta S.R., Brunet A., and Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 13 (1999) 2905-2927
7. Fadok V., Voelker D., Campbell P., Cohen J., Bratton D., and Henson P. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 (1992) 2207-2216
8. Fujita K., Matsuda E., Sekine K., Iigo M., and Tsuda H. Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats. Carcinogenesis 25 (2004) 1961-1966
9. Fujita K., Matsuda E., Sekine K., Iigo M., and Tsuda H. Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat. Cancer Lett. 213 (2004) 21-29
10. Gao T., Furnari F., and Newton A.C. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell. 18 (2005) 13-24
11. Goetzl E.J., and An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 12 (1998) 1589-1598
12. Gong, Y., Slee, R.B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A.M., Wang, H., Cundy, T., Glorieux, F.H., Lev, D., Zacharin, M., Oexle, K., Marcelino, J., Suwairi, W., Heeger, S., Sabatakos, G., Apte, S., Adkins, W.N., Allgrove, J., Arslan-Kirchner, M., Batch, J.A., Beighton, P., Black, G.C., Boles, R.G., Boon, L.M., Borrone, C., Brunner, H.G., Carle, G.F., Dallapiccola, B., De Paepe, A., Floege, B., Halfhide, M.L., Hall, B., Hennekam, R.C., Hirose, T., Jans, A., Juppner, H., Kim, C.A., Keppler-Noreuil, K., Kohlschuetter, A., LaCombe, D., Lambert, M., Lemyre, E., Letteboer, T., Peltonen, L., Ramesar, R.S., Romanengo, M., Somer, H., Steichen-Gersdorf, E., Steinmann, B., Sullivan, B., Superti-Furga, A., Swoboda, W., van den Boogaard, M.J., Van Hul, W., Vikkula, M., Votruba, M., Zabel, B., Garcia, T., Baron, R., Olsen, B.R., Warman, M.L.,Osteoporosis-Pseudoglioma Syndrome Collaborative G., 2001. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell, 107, 513-523.
13. Grey A., Banovic T., Naot D., Hill B., Callon K., Reid I., and Cornish J. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not p42/44 mitogen-activated protein kinases. Endocrinology 142 (2001) 1098-1106
14. Grey A., Banovic T., Zhu Q., Watson M., Callon K., Palmano K., Ross J., Naot D., Reid I.R., and Cornish J. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol. Endocrinol. 18 (2004) 2268-2278
15. Grey A., Chen Q., Callon K., Xu X., Reid I.R., and Cornish J. The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase. Endocrinology 143 (2002) 4755-4763
16. Grey A., Chen Q., Xu X., Callon K., and Cornish J. Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic cells. Endocrinology 144 (2003) 4886-4893
17. Herz J., Gotthardt M., and Willnow T.E. Cellular signalling by lipoprotein receptors. Curr. Opin. Lipidol. 11 (2000) 161-166
18. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., and Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J. Clin. Invest. 104 (1999) 439-446
19. Legrand D., Vigie K., Said E.A., Elass E., Masson M., Slomianny M.C., Carpentier M., Briand J.P., Mazurier J., and Hovanessian A.G. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur. J. Biochem. 271 (2004) 303-317
20. Loukinova E., Ranganathan S., Kuznetsov S., Gorlatova N., Migliorini M.M., Loukinov D., Ulery P.G., Mikhailenko I., Lawrence D.A., and Strickland D.K. Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J. Biol. Chem. 277 (2002) 15499-15506
21. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21 (2000) 115-137
22. Moolenaar W.H. Bioactive lysophospholipids and their G protein-coupled receptors. Exp. Cell Res. 253 (1999) 230-238
23. Niemeier A., Kassem M., Toedter K., Wendt D., Ruether W., Beisiegel U., and Heeren J. Expression of LRP1 by human osteoblasts: a mechanism for the delivery of lipoproteins and vitamin K-1 to bone. J. Bone Miner. Res. 20 (2005) 283-293
24. Strickland D.K., Gonias S.L., and Argraves W.S. Diverse roles for the LDL receptor family. Trends Endocrinol. Metab. 13 (2002) 66-74
25. Suzuki Y.A., and Lonnerdal B. Characterization of mammalian receptors for lactoferrin. Biochem. Cell Biol. 80 (2002) 75-80
26. Suzuki Y.A., Shin K., and Lonnerdal B. Molecular cloning and functional expression of a human intestinal lactoferrin receptor. Biochemistry (Mosc.) 40 (2001) 15771-15779
27. Takayama Y., Takahashi H., Mizumachi K., and Takezawa T. Low density lipoprotein receptor-related protein (LRP) is required for lactoferrin-enhanced collagen gel contractile activity of human fibroblasts. J. Biol. Chem. 278 (2003) 22112-22118
28. Talukder M.J., Takeuchi T., and Harada E. Characteristics of lactoferrin receptor in bovine intestine: higher binding activity to the epithelium overlying Peyer's patches. J. Vet. Med., Ser. A 50 (2003) 123-131
29. Tinari A., Pietrantoni A., Ammendolia M.G., Valenti P., and Superti F. Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro. Int. J. Antimicrob. Agents 25 (2005) 433-438
30. Tsuda H., Sekine K., Fujita K., and Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms-a review of experimental and clinical studies. Biochem. Cell Biol. 80 (2002) 131-136
31. Tsuda H., Sekine K., Takasuka N., Toriyama-Baba H., and Iigo M. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals. Biofactors 12 (2000) 83-88
32. Weinstein R.S., Jilka R.L., Parfitt A.M., and Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102 (1998) 274-282
33. Weinstein R.S., and Manolagas S.C. Apoptosis and osteoporosis. Am. J. Med. 108 (2000) 153-164
34. Willnow T.E., Goldstein J.L., Orth K., Brown M.S., and Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267 (1992) 26172-26180
35. Yang M., Huang H., Li J., Li D., and Wang H. Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. FASEB J. 18 (2004) 1920-1921
36. Yang M., Zhong W.W., Srivastava N., Slavin A., Yang J.X., Hoey T., and An S.Z. G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the beta-catenin pathway. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 6027-6032